Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2025-03-28 Regulatory Filings
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2025-03-28 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the outcome of a Board Meeting of Unichem Laboratories Limited. It details decisions made by the Board, specifically the approval to transfer a subsidiary's stake and the proposal to close a manufacturing facility of another subsidiary. The document references compliance with SEBI Listing Regulations and provides detailed annexures about the transactions, including financial figures and timelines. There is no presentation of full financial statements or comprehensive financial performance data typical of Annual or Interim Reports. Instead, it is an announcement of corporate actions decided by the Board. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management. The document length (7277 characters) and content confirm it is not a brief report publication announcement or a regulatory filing. Therefore, the classification is MANG with high confidence.
2025-03-28 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges regarding the closure of the trading window for insiders and designated persons. It references compliance with insider trading regulations and specifies the trading window closure period around the announcement of quarterly and annual financial results. The document is short (1297 characters) and serves as a regulatory announcement related to trading restrictions rather than containing any financial data, earnings, or report content. It does not present financial results, management discussion, or any report itself. Therefore, it is best classified as a Regulatory Filing (RNS), which covers compliance documents and miscellaneous regulatory announcements that do not fit other categories.
2025-03-25 English
Intimation of Closure of Trading Window
Regulatory Filings
2025-03-25 English
Capacity addition
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information by listed companies. The content describes completion of capacity expansion of an API plant, with details on capacity, investment, and financing. This is a typical example of a Capital/Financing Update as it informs about a significant capital expenditure and capacity expansion. The document is not a full financial report, earnings release, or management discussion, but an update on capital investment and related financing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is short and focused on a specific event, consistent with CAP filings.
2025-03-20 English
Disclosure under Regulation 30 of LODR
Regulatory Filings
2025-03-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.